<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome

Rivas, Marta ; Pichel, Mariana ; Zylberman, Vanesa Icon; Colonna, Mariana ; Valerio, Marina Paula Icon; Massa, Carolina ; Pardo, Romina Paola Icon; Ciocchini, Andres Eduardo Icon; Sanguineti, Santiago Icon; Roubicek, Ian ; Spatz, Linus ; Goldbaum, Fernando Alberto Icon

Otros responsables

Fecha

06/2025

Editorial

MDPI

Revista

Toxins

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

2072-6651

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Resumen

Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI). Shiga toxin (Stx)-producing Escherichia coli-associated HUS (STEC-HUS) is one of the leading causes of AKI in children. Approximately 1.5 to 3% of children die during the acute phase, and about 30% experience long-term renal sequelae. Argentina has the highest incidence of STEC-HUS globally. Given the prominent role of Stx in its pathophysiology, STEC-HUS is considered more of a toxemia than a bacterial disease. Stx transport occurs before and after the STEC-HUS onset, allowing for the distinction between an early toxemia phase and an advanced toxemia phase. In this review, we present our efforts to develop INM004, an anti-Stx treatment aimed at ameliorating or preventing the clinical consequences of STEC-HUS. We describe the protein engineering that facilitated this development and the clinical path to demonstrate the safety and efficacy of INM004. This immunotherapy could represent a new step in the treatment of STEC-HUS, which could potentially prevent long-term damage. If phase 3 trials are successful, earlier and broader use of INM004 is envisioned. We also discuss the potential impact of INM004 therapy, targeted vaccination strategies, and new diagnostic tools for this disease.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by